Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)
Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)
The primary purpose of the study is to determine if GARDASIL (V501) with four components is
 able to prevent cervical cancer, cervical dysplasia, including Cervical Intraepithelial
 Neoplasia (CIN)(Any Grade) and Adenocarcinoma In Situ (AIS), and genital warts.
Inclusion Criteria:

 -  Female with an intact uterus with lifetime history of 0-4 sexual partners

 Exclusion Criteria:

 -  Prior Human Papillomavirus (HPV) vaccination

 -  Prior abnormal paps

 -  History of genital warts